Literature DB >> 9077543

Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins.

S P Hogan1, A Mould, H Kikutani, A J Ramsay, P S Foster.   

Abstract

In this investigation we have used a mouse model containing certain phenotypic characteristics consistent with asthma and IL-4- and CD40-deficient mice to establish the role of this cytokine and allergen-specific immunoglobulins in the initiation of airways hyperreactivity and morphological changes to the airways in responses to aeroallergen challenge. Sensitization and aerosol challenge of mice with ovalbumin resulted in a severe airways inflammatory response which directly correlated with the induction of extensive airways damage and airways hyperreactivity to beta-methacholine. Inflammatory infiltrates were primarily characterized by the presence of CD4+ T cells and eosinophils. In IL-4-deficient mice, the recruitment of airways eosinophils was impaired, but not abolished in response to aeroallergen. Moreover, the characteristic airways damage and hyperreactivity normally resulting from allergen inhalation were not attenuated. Induction of these structural and functional changes to the airways occurred in the absence of ovalbumin-specific IgE and IgG1, but IgG2a and IgG3 were detected in the sera of IL-4-deficient mice. CD4+ T cells isolated from both wild-type and IL-4-deficient mice given ovalbumin produced significant levels of IL-5 after in vitro stimulation. Treatment of IL-4-deficient mice with anti-IL-5 mAb before aeroallergen challenge abolished blood and airways eosinophilia, lung damage, and airways hyperreactivity. These results indicate that IL-4 is not essential for the development of IL-5-producing CD4+ T cells or for the induction of eosinophilic inflammation and airways damage and hyperreactivity. In response to sensitization and aerosol challenge, CD40-deficient mice did not produce ovalbumin-specific IgE, IgG isotypes, or IgA, and airways inflammation and hyperreactivity were not attenuated. Our results suggest that allergic airways disease can occur via pathways which operate independently of IL-4 and allergen-specific immunoglobulins. Activation of these pathways is intimately associated with IL-5 and eosinophilic inflammation. Such pathways may play a substantive role in the etiology of asthma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9077543      PMCID: PMC507949          DOI: 10.1172/JCI119292

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway.

Authors:  D H Broide; G J Gleich; A J Cuomo; D A Coburn; E C Federman; L B Schwartz; S I Wasserman
Journal:  J Allergy Clin Immunol       Date:  1991-10       Impact factor: 10.793

2.  Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage.

Authors:  C Walker; E Bode; L Boer; T T Hansel; K Blaser; J C Virchow
Journal:  Am Rev Respir Dis       Date:  1992-07

3.  Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing.

Authors:  V Del Pozo; B De Andrés; E Martín; B Cárdaba; J C Fernández; S Gallardo; P Tramón; F Leyva-Cobian; P Palomino; C Lahoz
Journal:  Eur J Immunol       Date:  1992-07       Impact factor: 5.532

4.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

Authors:  D S Robinson; Q Hamid; S Ying; A Tsicopoulos; J Barkans; A M Bentley; C Corrigan; S R Durham; A B Kay
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

5.  Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma.

Authors:  P J Mauser; A Pitman; A Witt; X Fernandez; J Zurcher; T Kung; H Jones; A S Watnick; R W Egan; W Kreutner
Journal:  Am Rev Respir Dis       Date:  1993-12

6.  Effect of murine recombinant interleukin-5 on bronchial reactivity in guinea-pigs.

Authors:  T Iwama; H Nagai; N Tsuruoka; A Koda
Journal:  Clin Exp Allergy       Date:  1993-01       Impact factor: 5.018

7.  Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression.

Authors:  P F Weller; T H Rand; T Barrett; A Elovic; D T Wong; R W Finberg
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

8.  Disruption of the murine IL-4 gene blocks Th2 cytokine responses.

Authors:  M Kopf; G Le Gros; M Bachmann; M C Lamers; H Bluethmann; G Köhler
Journal:  Nature       Date:  1993-03-18       Impact factor: 49.962

9.  CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea.

Authors:  H Nakajima; I Iwamoto; S Tomoe; R Matsumura; H Tomioka; K Takatsu; S Yoshida
Journal:  Am Rev Respir Dis       Date:  1992-08

10.  Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion.

Authors:  S Dubucquoi; P Desreumaux; A Janin; O Klein; M Goldman; J Tavernier; A Capron; M Capron
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  50 in total

1.  Abrogation of lung inflammation in sensitized Stat6-deficient mice is dependent on the allergen inhalation procedure.

Authors:  A Trifilieff; A El-Hasim; R Corteling; C E Owen
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 2.  Acute and chronic airway responses to viral infection: implications for asthma and chronic obstructive pulmonary disease.

Authors:  Michael J Holtzman; Jeffrey W Tyner; Edy Y Kim; Mindy S Lo; Anand C Patel; Laurie P Shornick; Eugene Agapov; Yong Zhang
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis.

Authors:  J M Spergel; E Mizoguchi; H Oettgen; A K Bhan; R S Geha
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 4.  The future of asthma therapy: integrating clinical and experimental studies.

Authors:  David B Corry; Farrah Kheradmand
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1).

Authors:  Rocio T Martinez-Nunez; Fethi Louafi; Tilman Sanchez-Elsner
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

Review 6.  Importance of cytokines in murine allergic airway disease and human asthma.

Authors:  Fred D Finkelman; Simon P Hogan; Gurjit K Khurana Hershey; Marc E Rothenberg; Marsha Wills-Karp
Journal:  J Immunol       Date:  2010-02-15       Impact factor: 5.422

7.  Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice.

Authors:  X F Lei; Y Ohkawara; M R Stämpfli; C Mastruzzo; R A Marr; D Snider; Z Xing; M Jordana
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

8.  House Dust Mite-Induced Allergic Airway Disease Is Independent of IgE and FcεRIα.

Authors:  Christopher G McKnight; Joseph A Jude; Zhenqi Zhu; Reynold A Panettieri; Fred D Finkelman
Journal:  Am J Respir Cell Mol Biol       Date:  2017-12       Impact factor: 6.914

Review 9.  Defining and adjusting divergent host responses to viral infection.

Authors:  Michael J Holtzman; Edy Y Kim; Mindy S Lo; Jeffrey W Tyner; Laurie P Shornick; Kaharu C Sumino; Yong Zhang
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

10.  Viral induction of a chronic asthma phenotype and genetic segregation from the acute response.

Authors:  Michael J Walter; Jeffrey D Morton; Naohiro Kajiwara; Eugene Agapov; Michael J Holtzman
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.